Hypoxia-inducible factor 1 alpha in high-risk breast cancer: An independent prognostic parameter?

Breast Cancer Research

Volumn 6, Issue 3, 2004, Pages

  Gruber, Günther ^a   Greiner, Richard H ^a   Hlushchuk, Ruslan ^b   Aebersold, Daniel M ^a   Altermatt, Hans J ^a   Berclaz, Gilles ^a   Djonov, Valentin ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Breast cancer; Hypoxia inducible factor 1 alpha; Prognostic marker; Tumor hypoxia

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; METHOTREXATE; PACLITAXEL; PREDNISONE; TAMOXIFEN; TOREMIFENE; VINCRISTINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; HIF1A PROTEIN, HUMAN; PROGESTERONE RECEPTOR; TAXOID; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; FEMALE; LIFE TABLE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RISK; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIFE TABLES; LYMPHATIC METASTASIS; METHOTREXATE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PACLITAXEL; PREDNISONE; PROGNOSIS; RECEPTORS, PROGESTERONE; RISK; SURVIVAL ANALYSIS; TAMOXIFEN; TAXOIDS; TRANSCRIPTION FACTORS; VINCRISTINE;

EID: 3142724677     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr775     Document Type: Article

References (29)

1. Stone HB, Brown JM, Phillips TL, Sutherland RM: Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res. 1993, 136: 422-434.
2. Raleigh JA, Dewhirst MW, Thrall DE: Measuring tumor hypoxia. Semin Radiat Oncol. 1996, 6: 37-45.
3. Semenza GL: Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol. 2002, 64: 993-998. 10.1016/S0006-2952(02)01168-1.
4. Vukovic V, Haugland HK, Nicklee T, Morrison AJ, Hedley DW: Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res. 2001, 61: 7394-7398.
5. Haugland HK, Vukovic V, Pintilie M, Fyles AW, Milosevic M, Hill RP, Hedley DW: Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys. 2002, 53: 854-861. 10.1016/S0360-3016(02)02815-8.
6. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E: Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst. 2001, 93: 309-314. 10.1093/jnci/93.4.309.
7. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59: 5830-5835.
8. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G, Austrian Breast and Colorectal Cancer Study Group: Overexpression of hypoxia-inducible factor 1α is associated with an unfavourable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 2002, 8: 1831-1837.
9. Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E: Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer. 2003, 97: 1573-1581. 10.1002/cncr.11246.
10. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL: Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 2001, 61: 2911-2916.
11. Reynolds TY, Rockwell S, Glazer PM: Genetic instability induced by the tumor microenvironment. Cancer Res. 1996, 56: 5754-5757.
12. Rofstad EK: Microenvironment-induced cancer metastasis. Int J Radiat Biol. 2000, 76: 589-605. 10.1080/095530000138259.
13. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996, 379: 88-91. 10.1038/379088a0.
14. Teicher BA, Holden SA, al-Achi A, Herman TS: Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res. 1990, 50: 3339-3344.
15. 2 tension measurements. Cancer Res. 1991, 51: 3316-3322.
16. 2 histography. Br J Cancer. 1992, 66: 919-924.
17. 2-histography. Adv Exp Med Biol. 1994, 345: 451-458.
18. Birner P, Gatterbauer B, Oberhuber G, Schindl M, Rossler K, Prodinger A, Budka H, Hainfellner JA: Expression of hypoxia-inducible factor 1α in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer. 2001, 92: 165-171. 10.1002/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F.
19. Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI: Tumor and Angiogenesis Research Group. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer. 2002, 95: 1055-1063. 10.1002/cncr.10774.
20. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G: Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000, 60: 4693-4696.
21. Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, Altermatt HJ, Mazzucchelli L, Greiner RH, Gruber G: Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys. 2003, 56: 494-501. 10.1016/S0360-3016(02)04579-0.
22. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G: Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res. 2001, 7: 1661-1668.
23. Koukourakis MI, Giatromanolaki A, Skarlatos J, Corti L, Blandamura S, Piazza M, Gatter KC, Harris AL: Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 2001, 61: 1830-1832.
24. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL: Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer. 2001, 85: 881-890. 10.1054/bjoc.2001.2018.
25. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, Talks K, Gatter KC, Harris AL: Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002, 53: 1192-1202. 10.1016/S0360-3016(02)02848-1.
26. Nakayama K, Kanzaki A, Hata K, Katabuchi H, Okamura H, Miyazaki K, Fukumoto M, Takebayashi Y: Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett. 2002, 176: 215-223. 10.1016/S0304-3835(01)00762-5.
27. Volm M, Koomagi R: Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res. 2000, 20: 1527-1533.
28. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S, Harris AL: Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 2002, 62: 2493-2497.
29. Dai S, Huang ML, Hsu CY, Chao KS: Inhibition of hypoxia inducible factor 1 alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys. 2003, 55: 1027-1036. 10.1016/S0360-3016(02)04507-8.